Publications
Academic Articles
2024
Editorial: Reviews in breast cancer: 2023.
Frontiers in oncology.
14
[DOI] 10.3389/fonc.2024.1488263.
[PMID] 39479015.
2023
Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector.
Frontiers in immunology.
14
[DOI] 10.3389/fimmu.2023.1305937.
[PMID] 38077380.
2022
Advances and challenges of CAR T therapy and suitability of animal models (Review).
Molecular and clinical oncology.
17(3)
[DOI] 10.3892/mco.2022.2567.
[PMID] 35949897.
2022
Cancer in sub-Saharan Africa: a Lancet Oncology Commission.
The Lancet. Oncology.
23(6):e251-e312
[DOI] 10.1016/S1470-2045(21)00720-8.
[PMID] 35550267.
2022
Cancer research across Africa: a comparative bibliometric analysis.
BMJ global health.
7(11)
[DOI] 10.1136/bmjgh-2022-009849.
[PMID] 36356985.
2022
Women’s cancers in Sudan with a focus on cervical cancer: turmoil, geopolitics and opportunities.
Ecancermedicalscience.
16
[DOI] 10.3332/ecancer.2022.1433.
[PMID] 36200016.
2021
Erratum: Prostate cancer clinical characteristics and outcomes in Central Sudan.
Ecancermedicalscience.
15
[DOI] 10.3332/ecancer.2021.1265.
[PMID] 34567250.
2020
Author Correction: DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.
Scientific reports.
10(1)
[DOI] 10.1038/s41598-020-62220-7.
[PMID] 32193463.
2020
DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.
Scientific reports.
10(1)
[DOI] 10.1038/s41598-020-59260-4.
[PMID] 32051475.
2020
Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.
Cancers.
12(2)
[DOI] 10.3390/cancers12020418.
[PMID] 32053966.
2020
Partnerships and Collaborations: The Right Alliances for Clinical Trials in Africa.
JCO global oncology.
6:954-958
[DOI] 10.1200/JGO.19.00194.
[PMID] 32614730.
2020
Prostate cancer clinical characteristics and outcomes in Central Sudan.
Ecancermedicalscience.
14
[DOI] 10.3332/ecancer.2020.1116.
[PMID] 33209107.
2020
Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis.
Breast cancer (Dove Medical Press).
12:57-67
[DOI] 10.2147/BCTT.S236168.
[PMID] 32273752.
2019
LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.
Breast cancer (Dove Medical Press).
11:1-12
[DOI] 10.2147/BCTT.S185960.
[PMID] 30588086.
2019
Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors.
Molecular oncology.
13(6):1400-1418
[DOI] 10.1002/1878-0261.12494.
[PMID] 31026363.
2019
Magnetic Focus Lateral Flow Sensor for Detection of Cervical Cancer Biomarkers.
Analytical chemistry.
91(4):2876-2884
[DOI] 10.1021/acs.analchem.8b04848.
[PMID] 30632735.
2018
Canine mammary tumors as a model for human disease.
Oncology letters.
15(6):8195-8205
[DOI] 10.3892/ol.2018.8411.
[PMID] 29928319.
2018
Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
Vaccine.
36(45):6744-6751
[DOI] 10.1016/j.vaccine.2018.09.031.
[PMID] 30266488.
2018
Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.
Oncotarget.
9(14):11677-11690
[DOI] 10.18632/oncotarget.24433.
[PMID] 29545929.
2018
Significance of Using SYPRO Ruby against CBB R-250 for Visualizing Haematoxylin Stained Proteins in Gels.
Journal of oncology research and therapy.
4(1)
[PMID] 31058263.
2017
Changing global policy to deliver safe, equitable, and affordable care for women’s cancers.
Lancet (London, England).
389(10071):871-880
[DOI] 10.1016/S0140-6736(16)31393-9.
[PMID] 27814964.
2016
Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.
International journal of radiation oncology, biology, physics.
94(3):440-9
[DOI] 10.1016/j.ijrobp.2015.10.063.
[PMID] 26867873.
2016
Incidence and survival rates of ovarian cancer in low-income women in Sudan.
Molecular and clinical oncology.
5(6):823-828
[DOI] 10.3892/mco.2016.1068.
[PMID] 28105363.
2016
Point-of-care test for cervical cancer in LMICs.
Oncotarget.
7(14):18787-97
[DOI] 10.18632/oncotarget.7709.
[PMID] 26934314.
2015
A multi-targeted approach to suppress tumor-promoting inflammation.
Seminars in cancer biology.
35 Suppl:S151-S184
[DOI] 10.1016/j.semcancer.2015.03.006.
[PMID] 25951989.
2015
Breast cancer metastasis and the lymphatic system.
Oncology letters.
10(3):1233-1239
[PMID] 26622656.
2015
Broad targeting of angiogenesis for cancer prevention and therapy.
Seminars in cancer biology.
35 Suppl(Suppl):S224-S243
[DOI] 10.1016/j.semcancer.2015.01.001.
[PMID] 25600295.
2015
Broad targeting of resistance to apoptosis in cancer.
Seminars in cancer biology.
35 Suppl:S78-S103
[DOI] 10.1016/j.semcancer.2015.03.001.
[PMID] 25936818.
2015
Cancer prevention and therapy through the modulation of the tumor microenvironment.
Seminars in cancer biology.
35 Suppl(Suppl):S199-S223
[DOI] 10.1016/j.semcancer.2015.02.007.
[PMID] 25865775.
2015
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
Seminars in cancer biology.
35 Suppl(Suppl):S276-S304
[DOI] 10.1016/j.semcancer.2015.09.007.
[PMID] 26590477.
2015
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
Seminars in cancer biology.
35 Suppl:S55-S77
[DOI] 10.1016/j.semcancer.2015.02.005.
[PMID] 25749195.
2015
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition.
Seminars in cancer biology.
35 Suppl(Suppl):S5-S24
[DOI] 10.1016/j.semcancer.2015.03.005.
[PMID] 25869442.
2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategies.
Seminars in cancer biology.
35 Suppl:S185-S198
[DOI] 10.1016/j.semcancer.2015.03.004.
[PMID] 25818339.
2015
Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers.
Cancer medicine.
4(3):447-56
[DOI] 10.1002/cam4.378.
[PMID] 25641872.
2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
Seminars in cancer biology.
35 Suppl(Suppl):S25-S54
[DOI] 10.1016/j.semcancer.2015.02.006.
[PMID] 25892662.
2015
Therapeutic targeting of replicative immortality.
Seminars in cancer biology.
35 Suppl(Suppl):S104-S128
[DOI] 10.1016/j.semcancer.2015.03.007.
[PMID] 25869441.
2014
Cancer incidence in Khartoum, Sudan: first results from the Cancer Registry, 2009-2010.
Cancer medicine.
3(4):1075-84
[DOI] 10.1002/cam4.254.
[PMID] 24821265.
2014
Sorting reality from what we think we know about breast cancer in Africa.
PLoS medicine.
11(9)
[DOI] 10.1371/journal.pmed.1001721.
[PMID] 25203049.
2013
Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study.
The Lancet. Oncology.
14(4):363-70
[DOI] 10.1016/S1470-2045(12)70583-1.
[PMID] 23375833.
2012
Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors.
Journal of controlled release : official journal of the Controlled Release Society.
158(3):386-92
[DOI] 10.1016/j.jconrel.2011.12.001.
[PMID] 22178261.
2012
Role of epigenetics in cancer health disparities.
Methods in molecular biology (Clifton, N.J.).
863:395-410
[DOI] 10.1007/978-1-61779-612-8_25.
[PMID] 22359308.
2011
Effect of a photoactivated rhodium complex in melanoma.
Anti-cancer drugs.
22(9):896-904
[DOI] 10.1097/CAD.0b013e32834850a5.
[PMID] 21642837.
2010
Breast cancer burden in central Sudan.
International journal of women's health.
2:77-82
[PMID] 21072300.
2010
Effects of short-term celecoxib treatment in patients with invasive transitional cell carcinoma of the urinary bladder.
Molecular cancer therapeutics.
9(5):1371-7
[DOI] 10.1158/1535-7163.MCT-10-0049.
[PMID] 20423998.
2010
Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol.
Anticancer research.
30(12):4907-13
[PMID] 21187469.
2010
Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.
BMC cancer.
10
[DOI] 10.1186/1471-2407-10-156.
[PMID] 20412586.
2009
Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer.
Prostaglandins, leukotrienes, and essential fatty acids.
80(1):9-18
[DOI] 10.1016/j.plefa.2008.10.003.
[PMID] 19058955.
2008
Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Experimental biology and medicine (Maywood, N.J.).
233(6):708-20
[DOI] 10.3181/0710-RM-281.
[PMID] 18408141.
2008
Proteomic-based approach for biomarkers discovery in early detection of invasive urothelial carcinoma.
Proteomics. Clinical applications.
2(1):78-89
[DOI] 10.1002/prca.200780027.
[PMID] 21136781.
2008
Proteomics and genomics of urinary bladder cancer.
Proteomics. Clinical applications.
2(9):1194-207
[DOI] 10.1002/prca.200780089.
[PMID] 21136917.
2007
Bacteria-mediated delivery of nanoparticles and cargo into cells.
Nature nanotechnology.
2(7):441-9
[DOI] 10.1038/nnano.2007.149.
[PMID] 18654330.
2007
Spontaneous mammary intraepithelial lesions in dogs–a model of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
16(11):2247-56
[PMID] 17982119.
2007
Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
Prostaglandins, leukotrienes, and essential fatty acids.
76(4):245-50
[PMID] 17383864.
2006
Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects.
Molecular cancer therapeutics.
5(2):329-36
[PMID] 16505106.
2006
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research.
12(2):353-60
[PMID] 16428472.
2006
On the possibility of applying noncovalent dyes for protein labeling in isoelectric focusing.
Analytical biochemistry.
350(2):263-7
[PMID] 16460657.
2005
Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
Bioconjugate chemistry.
16(6):1580-8
[PMID] 16287258.
2005
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
Cancer gene therapy.
12(1):46-53
[PMID] 15486559.
2005
Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
Human gene therapy.
16(9):1097-109
[PMID] 16149908.
2004
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
Cancer gene therapy.
11(11):757-66
[PMID] 15359289.
2003
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Molecular cancer therapeutics.
2(2):183-8
[PMID] 12589035.
2002
Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.
Advances in experimental medicine and biology.
507:377-80
[PMID] 12664613.
2002
Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Cancer research.
62(2):356-8
[PMID] 11809678.
Grants
Sep 2023
ACTIVE
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Other
Funding: NATL INST OF HLTH NCI
Jun 2023
ACTIVE
UF Health Cancer Center Support Grant
Role: Other
Funding: NATL INST OF HLTH NCI
Education
PhD
1990
·
Purdue University
MS
1982
·
Cornell Univesity
DVM
1977
·
Khatroum University
Contact Details
Emails:
- Business:
- smohammed2@ufl.edu
Addresses:
- Business Street:
-
2033 MOWRY RD
GAINESVILLE FL 32610